| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | President And CEO | Director
2 companies
Torley Helen is a President And CEO at HALOZYME THERAPEUTICS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $54.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2021 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 50,000 | $46.19 | $2,309,454.44 | -4.3% | |
| Feb 1, 2021 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 50,000 | $47.84 | $2,391,917.64 | -5.0% | |
| Nov 25, 2020 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 50,000 | $40.73 | $2,036,567.72 | -4.8% |